- Targeted stakeholdersMay increase public and clinician awareness, prompting more regular TD screening and recognition.
- Targeted stakeholdersCould lead to more diagnoses and referrals, increasing treatment uptake and specialist care.
- Targeted stakeholdersEarlier identification and treatment might reduce long-term functional impairment and related costs.
Expressing support for the designation of the week of May 3, 2026, through May 9, 2026, as "Tardive Dyskinesia Awareness Week".
Referred to the House Committee on Energy and Commerce.
This House resolution expresses support for designating May 3–9, 2026, as "Tardive Dyskinesia Awareness Week" and encourages Americans to become better informed about tardive dyskinesia.
The text notes TD causes, affected populations, screening recommendations, FDA-approved treatments, and the need for monitoring by health care providers.
As a House simple resolution it is non‑binding and cannot become law; adoption is likely but it does not create statutory law.
Relative to its intended legislative type, this bill is a straightforward commemorative resolution that clearly defines the condition it seeks to highlight and precisely designates dates for an awareness week while offering a simple call to action for individuals.
Liberals push for funding and coverage; conservatives prefer symbolic action only
Who stands to gain, and who may push back.
- Federal agenciesIs a symbolic, non-binding resolution that provides no federal funding or regulatory changes.
- ManufacturersAwareness drives could increase demand for pharmaceutical treatments, benefiting manufacturers.
- Targeted stakeholdersCould inadvertently stigmatize people taking dopamine‑blocking medications by highlighting medication-associated side e…
Why the argument around this bill splits.
Liberals push for funding and coverage; conservatives prefer symbolic action only
Likely strongly supportive of awareness and of highlighting impacts on people with mental and gastrointestinal disorders.
Would welcome reduced stigma and better screening, while pushing for concrete follow-through like access and coverage for treatments.
Generally supportive because it is nonbinding, low-cost, and raises health awareness.
Would look for clarity that it imposes no new unfunded mandates and suggests coordination with existing public-health efforts.
Likely supportive of a symbolic, awareness-focused resolution but cautious about any implied federal expansion or mandates.
Prefers state, private-sector, and clinician-led responses rather than new federal programs.
The path through Congress.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
As a House simple resolution it is non‑binding and cannot become law; adoption is likely but it does not create statutory law.
- Whether House leadership will schedule floor consideration
- Whether a companion Senate resolution will be introduced
Recent votes on the bill.
No vote history yet
The bill has not accumulated any surfaced votes yet.
Go deeper than the headline read.
Liberals push for funding and coverage; conservatives prefer symbolic action only
As a House simple resolution it is non‑binding and cannot become law; adoption is likely but it does not create statutory law.
Relative to its intended legislative type, this bill is a straightforward commemorative resolution that clearly defines the condition it seeks to highlight and precisely designates dates for an awareness week while offe…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.